167 related articles for article (PubMed ID: 17072500)
1. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella ED; Moreau P
Cell Mol Life Sci; 2006 Nov; 63(22):2669-81. PubMed ID: 17072500
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.
Henriquet C; Gougat C; Combes A; Lazennec G; Mathieu M
Lung Cancer; 2007 May; 56(2):167-74. PubMed ID: 17207890
[TBL] [Abstract][Full Text] [Related]
3. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.
Lesport E; Baudhuin J; LeMaoult J; Sousa S; Doliger C; Carosella ED; Favier B
Hum Immunol; 2009 Dec; 70(12):1000-5. PubMed ID: 19654030
[TBL] [Abstract][Full Text] [Related]
4. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia modulates HLA-G gene expression in tumor cells.
Mouillot G; Marcou C; Zidi I; Guillard C; Sangrouber D; Carosella ED; Moreau P
Hum Immunol; 2007 Apr; 68(4):277-85. PubMed ID: 17400064
[TBL] [Abstract][Full Text] [Related]
6. Exosomes bearing HLA-G are released by melanoma cells.
Riteau B; Faure F; Menier C; Viel S; Carosella ED; Amigorena S; Rouas-Freiss N
Hum Immunol; 2003 Nov; 64(11):1064-72. PubMed ID: 14602237
[TBL] [Abstract][Full Text] [Related]
7. The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.
Sala FG; Del Moral PM; Pizzato N; Legrand-Abravanel F; Le Bouteiller P; Lenfant F
Immunogenetics; 2004 Dec; 56(9):617-24. PubMed ID: 15578261
[TBL] [Abstract][Full Text] [Related]
8. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
Menier C; Riteau B; Carosella ED; Rouas-Freiss N
Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA-G induces NF-kappaB activation in natural killer cells.
Zidi I; Guillard C; Carosella ED; Moreau P
J Physiol Biochem; 2010 Mar; 66(1):39-46. PubMed ID: 20405270
[TBL] [Abstract][Full Text] [Related]
10. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
11. Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells.
Guillard C; Zidi I; Marcou C; Menier C; Carosella ED; Moreau P
Mol Immunol; 2008 Jan; 45(2):419-27. PubMed ID: 17675239
[TBL] [Abstract][Full Text] [Related]
12. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
[TBL] [Abstract][Full Text] [Related]
13. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HLA-G production in JEG-3 choriocarcinoma cells by RNA interference.
Wengenmayer T; Poehlmann TG; Markert UR
Am J Reprod Immunol; 2004 Mar; 51(3):189-91. PubMed ID: 15209386
[TBL] [Abstract][Full Text] [Related]
15. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
Paul P; Rouas-Freiss N; Khalil-Daher I; Moreau P; Riteau B; Le Gal FA; Avril MF; Dausset J; Guillet JG; Carosella ED
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4510-5. PubMed ID: 9539768
[TBL] [Abstract][Full Text] [Related]
16. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
Cabrera T; Lara E; Romero JM; Maleno I; Real LM; Ruiz-Cabello F; Valero P; Camacho FM; Garrido F
Cancer Immunol Immunother; 2007 May; 56(5):709-17. PubMed ID: 16960691
[TBL] [Abstract][Full Text] [Related]
17. Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
Correale P; Procopio A; Celio L; Caraglia M; Genua G; Coppola V; Pepe S; Normanno N; Vecchio I; Palmieri G
Cancer Immunol Immunother; 1992; 34(4):272-8. PubMed ID: 1371427
[TBL] [Abstract][Full Text] [Related]
18. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
Rouas-Freiss N; Bruel S; Menier C; Marcou C; Moreau P; Carosella ED
Int J Cancer; 2005 Oct; 117(1):114-22. PubMed ID: 15880415
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune recognition of HLA-G-expressing choriocarcinoma cell line Jeg-3.
Burt D; Johnston D; Rinke de Wit T; Van den Elsen P; Stern PL
Int J Cancer Suppl; 1991; 6():117-22. PubMed ID: 2066177
[TBL] [Abstract][Full Text] [Related]
20. HLA-G expression in human melanoma cells: protection from NK cytolysis.
Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
